» Articles » PMID: 15136391

Can a Standardized Acupuncture Technique Palliate Disabling Breathlessness: a Single-blind, Placebo-controlled Crossover Study

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2004 May 12
PMID 15136391
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: The management of disabling breathlessness is poor, and a standardized form of acupuncture has been reported as offering benefit. This study was designed to evaluate the efficacy of standardized acupuncture treatment.

Design: A single-blind, randomized, crossover study.

Setting: This study was carried out on a domiciliary basis in Southampton (UK).

Interventions: This study evaluated a standardized acupuncture technique vs an appropriately validated placebo/control (mock transcutaneous electrical nerve stimulation [TENS]) for disabling, nonmalignant breathlessness (largely COPD). The acupuncture was provided by an appropriately trained nurse acupuncturist. Each patient received six treatments in each phase of the study, with an intervening 2-week washout period.

Measurements And Results: The primary outcome was worst breathlessness (visual analog scale, 0 to 100 mm), with the sample size based on an 80% power to detect a 10-mm difference between treatment means. Secondary outcomes included the St George's respiratory questionnaire score and treatment credibility.

Results: Thirty-six patients were entered into the study (33 with COPD), and 24 patients completed both treatment phases. The primary outcome improved significantly during the course of the study, but there were no significant treatment differences between acupuncture and the placebo/control of mock TENS for either primary or secondary outcomes. The placebo was shown to be a credible control. There was no evidence of a carryover effect from the first to second phase of the study.

Conclusion: This standardized acupuncture technique does not show specific efficacy in disabling nonmalignant breathlessness, but those entered into the study did experience clinically significant benefit from both treatments.

Citing Articles

The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.

Gao B, Wang S, Jiang S Med Rev (2021). 2024; 4(5):395-412.

PMID: 39444798 PMC: 11495473. DOI: 10.1515/mr-2024-0006.


Effectiveness and safety of acupuncture as an adjunctive therapy for chronic obstructive pulmonary disease: a randomised controlled trial.

Xu G, Luo Q, Sun M, Huang L, Liu J, Yang C BMC Complement Med Ther. 2024; 24(1):326.

PMID: 39227880 PMC: 11370288. DOI: 10.1186/s12906-024-04630-y.


Acupuncture for dyspnea and breathing physiology in chronic respiratory diseases: A systematic review and meta-analysis of randomized controlled trials.

Yu Y, Xiao W, Du L, Li Y, Xiong C, Liang F Heliyon. 2024; 10(10):e31176.

PMID: 38813170 PMC: 11133705. DOI: 10.1016/j.heliyon.2024.e31176.


Drug trials are more likely to disclose full placebo control information than non-drug trials: A cross-sectional study of participant information leaflets of placebo-controlled trials.

Won J, Han J, Ji Y, Ha D, Han B, Lee H Integr Med Res. 2024; 13(2):101043.

PMID: 38779540 PMC: 11109310. DOI: 10.1016/j.imr.2024.101043.


Efficacy of Acupuncture on Quality of Life, Functional Performance, Dyspnea, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Clinical Trial.

Fleury Cardoso R, Lacerda A, Lima V, de Oliveira L, de Oliveira S, Araujo R J Clin Med. 2022; 11(11).

PMID: 35683437 PMC: 9181529. DOI: 10.3390/jcm11113048.